导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -14.79% | 904/1050 |
| 近一周 | -2.41% | 903/1104 |
| 近一月 | -0.68% | 76/1103 |
| 近一季 | 1.12% | 251/1094 |
| 近半年 | -10.15% | 811/1074 |
| 近一年 | -18.95% | 890/1020 |
| 近两年 | 17.78% | 793/926 |
| 近三年 | 2.99% | 652/834 |
| 成立以来 | 249.93% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.44% 987/1070 |
-9.08% 892/1101 |
- - |
- - |
| 2025 | 12.24% 799/1065 |
8.23% 217/1014 |
-1.90% 835/1038 |
12.56% 796/1050 |
-6.08% 744/1065 |
| 2024 | 17.16% 130/1011 |
2.65% 179/960 |
-0.16% 319/983 |
14.70% 257/991 |
-0.34% 342/1011 |
| 2023 | -14.44% 499/952 |
2.92% 453/880 |
-6.01% 578/895 |
-5.33% 335/915 |
-6.57% 640/952 |
| 2022 | -20.32% 335/867 |
-20.60% 552/773 |
11.38% 210/806 |
-12.17% 401/845 |
2.57% 294/867 |
| 2021 | 10.34% 244/740 |
-2.54% 244/580 |
16.50% 211/659 |
-8.12% 452/704 |
5.76% 194/740 |
| 2020 | 79.06% 95/554 |
0.38% 154/419 |
32.94% 92/466 |
16.30% 124/517 |
15.38% 198/554 |
| 2019 | 57.52% 93/410 |
27.22% 532/1146 |
-1.92% 515/1228 |
13.52% 62/390 |
11.19% 127/410 |
| 2018 | -10.16% 8/349 |
- - |
-2.45% 127/990 |
-3.94% 411/1000 |
-6.16% 85/1080 |
| 2017 | 27.68% 52/285 |
- - |
- - |
- - |
- - |
| 2016 | 15.72% 3/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 工银文体产业股票A VS. 东吴新产业精选股票A(580008) |